Target intelligence / Profile preview

Bacterial Enzymes and Membranes

Molecular classification
Enzyme, Other
01

Overview

Bacterial Enzymes and Membranes represent a broad classification of therapeutic targets essential for the structural integrity, metabolic activity, and virulence of bacterial pathogens [1, 2]. This collective target group encompasses a wide variety of molecules, including integral membrane proteins, transporters, and enzymes involved in energy production, cell wall biosynthesis, and signal transduction [1, 6]. Many antimicrobial agents, ranging from clinical antiseptics like chlorhexidine to natural compounds such as cinnamaldehyde and various flavonoids, exert their effects by simultaneously disrupting the bacterial lipid bilayer and deactivating key metabolic enzymes [1, 2, 3]. This dual mechanism of action leads to increased membrane permeability, the leakage of essential cellular components, and the cessation of vital biochemical processes, ultimately resulting in bacterial death [6, 8]. These targets are central to the treatment of diverse conditions, including oral diseases like periodontitis and caries, as well as systemic infections caused by both Gram-positive and Gram-negative bacteria [1, 3, 4]. However, the non-specific nature of many membrane-active agents can lead to host cell toxicity, and the broad pressure exerted on these systems necessitates careful therapeutic management to mitigate the risk of antimicrobial resistance [1, 8].

Other names
Bacterial cell envelopeBacterial metabolic enzymesBacterial membrane proteinsBacterial cell wall and membrane
02

Mechanism of action

Simultaneous disruption of bacterial cell membrane integrity and inhibition of essential metabolic enzymes [1, 2, 6].

03

Biological functions

MetabolismCellular homeostasisBiofilm formationPathogenicitySignal transduction
04

Disease associations

InfectionPeriodontal diseaseCariesInflammation
05

Safety considerations

Host cell membrane toxicityNephrotoxicityAntimicrobial resistanceMicrobiome disruption
06

Interacting drugs

Chlorhexidine

6 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)Minimum bactericidal concentration (MBC)Bacterial colony forming units (CFU)Propidium iodide uptake

Beyond the preview

Go deeper on Bacterial Enzymes and Membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial Enzymes and Membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call